For research use only. Not for therapeutic Use.
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride(CAT: I015439) is a compound with potential therapeutic applications. It is a modified form of thalidomide, an immunomodulatory drug. The addition of the PEG3-C2-NH2 moiety to thalidomide enhances its solubility and pharmacokinetic properties. The hydrochloride form improves the compound’s stability and facilitates its use in various applications. Thalidomide derivatives have been studied for their anti-inflammatory, immunomodulatory, and anti-angiogenic effects, making them potential candidates for the treatment of various diseases, including cancer and inflammatory disorders.
Catalog Number | I015439 |
CAS Number | 2245697-84-9 |
Molecular Formula | C₂₃H₃₁ClN₄O₉ |
Purity | ≥95% |
Target | Autophagy |
Reference | [1]. Methods to induce targeted protein degradation through bifunctional molecules. WO2017007612A1. |